| Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow | 04/23/2025 | |
| Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer | 04/24/2025 | |
| Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationshi… | 12/20/2023 | |
| Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast C… | 01/02/2024 | |
